Similar articles

• Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: application of a computerized model fitting technique.

  Hancock AA, DeLean AL, Lefkowitz RJ. Hancock AA, et al. Mol Pharmacol. 1979 Jul;16(1):1-9. Mol Pharmacol. 1979. PMID: 39239 No abstract available.
• In vivo receptor binding of iodinated beta-adrenoceptor blockers.

  Eckelman WC, Gibson RE, Vieras F, Rzeszotarski WJ, Francis B, Reba RC. Eckelman WC, et al. J Nucl Med. 1980 May;21(5):436-42. J Nucl Med. 1980. PMID: 6103024
• The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro.

  Minneman KP, Hegstrand LR, Molinoff PB. Minneman KP, et al. Mol Pharmacol. 1979 Jul;16(1):21-33. Mol Pharmacol. 1979. PMID: 39243 No abstract available.
• [Adrenoreceptors of the heart].

  Matiushin AI. Matiushin AI. Farmakol Toksikol. 1986 Jan-Feb;49(1):107-13. Farmakol Toksikol. 1986. PMID: 3005030 Review. Russian. No abstract available.
• Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.

  Molenaar P, Chen L, Semmler AB, Parsonage WA, Kaumann AJ. Molenaar P, et al. Clin Exp Pharmacol Physiol. 2007 Oct;34(10):1020-8. doi: 10.1111/j.1440-1681.2007.04730.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17714089 Review.